Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Here's Why Invitae's Q1 Revenue Soared 61%

TheMotleyFool

0 0

Here's Why Invitae's Q1 Revenue Soared 61%Photo, wide shot, wide-angle lens, Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png

Invitae's (NYSE: NVTA) winning ways in 2020 have gone by the wayside so far in 2021. Shares of the medical genetics company are down more than 25% year to date.

The company announced its first-quarter results after the market closed Tuesday. Invitae's downtrend appears likely to continue with the healthcare stock slipping nearly 3% in after-hours trading. Here are the highlights from the company's Q1 update.

Image source: Getty Images.

Source Fool.com

Like: 0

NVTA

Teilen